Table 6. Misclassification matrices, (a) Mv and (b) Mc, of participants’ diagnoses and diagnoses calculated by the DST using clinical signs recorded during the study.
| (a) Mv | Participant Diagnosis: | |||||||||
| DST Diagnosis | ANA | BAB | COW | FAS | PGE | SCH | THL | TRY | Other | |
| Phase-1 | ANA | 0.524 | 0.000 | 0.000 | 0.039 | 0.027 | 0.000 | 0.009 | 0.040 | 0.000 |
| BAB | 0.012 | 0.791 | 0.000 | 0.003 | 0.000 | 0.000 | 0.003 | 0.001 | 0.069 | |
| COW | 0.259 | 0.070 | 0.980 | 0.062 | 0.115 | 0.125 | 0.101 | 0.088 | 0.103 | |
| FAS | 0.000 | 0.000 | 0.000 | 0.153 | 0.088 | 0.000 | 0.000 | 0.020 | 0.000 | |
| PGE | 0.000 | 0.012 | 0.000 | 0.173 | 0.410 | 0.000 | 0.008 | 0.076 | 0.000 | |
| SCH | 0.008 | 0.000 | 0.000 | 0.087 | 0.077 | 0.625 | 0.000 | 0.067 | 0.000 | |
| THL | 0.159 | 0.047 | 0.000 | 0.034 | 0.041 | 0.000 | 0.835 | 0.077 | 0.310 | |
| TRY | 0.039 | 0.081 | 0.020 | 0.450 | 0.241 | 0.250 | 0.036 | 0.631 | 0.207 | |
| Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.008 | 0.000 | 0.310 | |
| Phase-2 | ANA | 0.543 | 0.027 | 0.014 | 0.013 | 0.042 | 0.016 | 0.015 | 0.024 | 0.000 |
| BAB | 0.013 | 0.725 | 0.000 | 0.008 | 0.013 | 0.000 | 0.003 | 0.003 | 0.000 | |
| COW | 0.166 | 0.041 | 0.864 | 0.035 | 0.039 | 0.078 | 0.116 | 0.052 | 0.667 | |
| FAS | 0.017 | 0.027 | 0.000 | 0.080 | 0.091 | 0.000 | 0.013 | 0.009 | 0.000 | |
| PGE | 0.013 | 0.000 | 0.000 | 0.262 | 0.314 | 0.000 | 0.044 | 0.046 | 0.000 | |
| SCH | 0.008 | 0.023 | 0.000 | 0.043 | 0.107 | 0.297 | 0.012 | 0.030 | 0.000 | |
| THL | 0.100 | 0.054 | 0.050 | 0.144 | 0.058 | 0.188 | 0.666 | 0.028 | 0.000 | |
| TRY | 0.140 | 0.104 | 0.071 | 0.415 | 0.335 | 0.422 | 0.131 | 0.809 | 0.333 | |
| Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| (b) Mc | DST Diagnosis: | |||||||||
| Participant Diagnosis | ANA | BAB | COW | FAS | PGE | SCH | THL | TRY | Other | |
| Phase-1 | ANA | 0.825 | 0.074 | 0.286 | 0.000 | 0.000 | 0.032 | 0.099 | 0.027 | 0.000 |
| BAB | 0.000 | 0.836 | 0.014 | 0.000 | 0.003 | 0.000 | 0.005 | 0.010 | 0.000 | |
| COW | 0.000 | 0.000 | 0.221 | 0.000 | 0.000 | 0.000 | 0.000 | 0.003 | 0.000 | |
| FAS | 0.025 | 0.008 | 0.028 | 0.343 | 0.114 | 0.139 | 0.008 | 0.129 | 0.000 | |
| PGE | 0.045 | 0.000 | 0.134 | 0.513 | 0.702 | 0.322 | 0.027 | 0.180 | 0.000 | |
| SCH | 0.000 | 0.000 | 0.009 | 0.000 | 0.000 | 0.161 | 0.000 | 0.012 | 0.000 | |
| THL | 0.021 | 0.025 | 0.166 | 0.000 | 0.020 | 0.000 | 0.774 | 0.037 | 0.250 | |
| TRY | 0.084 | 0.008 | 0.128 | 0.143 | 0.161 | 0.346 | 0.063 | 0.585 | 0.000 | |
| Other | 0.000 | 0.049 | 0.014 | 0.000 | 0.000 | 0.000 | 0.023 | 0.017 | 0.750 | |
| Phase-2 | ANA | 0.825 | 0.047 | 0.225 | 0.079 | 0.019 | 0.037 | 0.083 | 0.060 | NA1 |
| BAB | 0.013 | 0.850 | 0.017 | 0.040 | 0.000 | 0.031 | 0.014 | 0.014 | NA | |
| COW | 0.006 | 0.000 | 0.345 | 0.000 | 0.000 | 0.000 | 0.012 | 0.009 | NA | |
| FAS | 0.020 | 0.032 | 0.049 | 0.397 | 0.416 | 0.201 | 0.126 | 0.188 | NA | |
| PGE | 0.051 | 0.040 | 0.043 | 0.344 | 0.379 | 0.377 | 0.039 | 0.115 | NA | |
| SCH | 0.002 | 0.000 | 0.007 | 0.000 | 0.000 | 0.088 | 0.011 | 0.012 | NA | |
| THL | 0.028 | 0.016 | 0.194 | 0.076 | 0.081 | 0.065 | 0.680 | 0.069 | NA | |
| TRY | 0.056 | 0.016 | 0.107 | 0.063 | 0.105 | 0.202 | 0.035 | 0.529 | NA | |
| Other | 0.000 | 0.000 | 0.011 | 0.000 | 0.000 | 0.000 | 0.000 | 0.002 | NA | |
In (a), M v , proportions of each participant diagnosis are shown for each DST diagnosis in columns summating to 1. In (b), M c , proportions of each DST diagnosis are shown for each participant diagnosis in columns summating to 1.
Leading diagonal indicating agreement, other cells indicating disagreement.
1NA: not applicable. [Other abbreviations as Table 4.].